1-4 of 4
Salvatore Perrone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab

Subject Area:
Further Areas , Oncology , Pharmacology
Federica Plano, Salvatrice Mancuso, Giulia Maria Camarda, Maria Giulia Butera, Giuseppe Sucato, Giuseppe Alecci, Ada Maria Florena, Salvatore Perrone, Sergio Mario Siragusa
Journal: Chemotherapy
Chemotherapy (2024) 69 (1): 35–39.
https://doi.org/10.1159/000533235
Published Online: 25 August 2023
View article titled, A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab
Open the PDF for A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab in another window
Journal Articles

Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1 mut -AML Who Has Become Ineligible for High-Dose Consolidation

Subject Area:
Further Areas , Oncology , Pharmacology
Natalia Cenfra, Gianfranco Lapietra, Salvatore Perrone, Maria Teresa Voso, Mariadomenica Divona, Sergio Mecarocci, Elettra Ortu La Barbera, Giuseppe Cimino
Journal: Chemotherapy
Chemotherapy (2022) 67 (1): 24–28.
https://doi.org/10.1159/000520205
Published Online: 12 January 2022
View article titled, Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1 mut -AML Who Has Become Ineligible for High-Dose Consolidation
Open the PDF for Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1 mut -AML Who Has Become Ineligible for High-Dose Consolidation in another window
Journal Articles

A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib

Subject Area:
Further Areas , Oncology , Pharmacology
Salvatore Perrone, Elettra Ortu La Barbera, Federica Viola, Elena Cipollone, Maria Cristina Scerpa, Roberta Siniscalchi, Tiziana Ottone, Maria Teresa Voso, Giuseppe Cimino
Journal: Chemotherapy
Chemotherapy (2021) 66 (4): 134–138.
https://doi.org/10.1159/000518356
Published Online: 24 August 2021
View article titled, A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib
Open the PDF for A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib in another window
Journal Articles

Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life

Subject Area:
Further Areas , Oncology , Pharmacology
Pierantonio Menna, Emanuela Salvatorelli, Maria Ilaria Del Principe, Salvatore Perrone, Livio Pagano, Francesco Marchesi, Giorgio Minotti
Journal: Chemotherapy
Chemotherapy (2021) 66 (1-2): 47–52.
https://doi.org/10.1159/000513989
Published Online: 05 March 2021
View article titled, Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life
Open the PDF for Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life in another window